CHRONIC URTICARIA
Clinical trials for CHRONIC URTICARIA explained in plain language.
Never miss a new study
Get alerted when new CHRONIC URTICARIA trials appear
Sign up with your email to follow new studies for CHRONIC URTICARIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New biosimilar aims to tame stubborn hives at lower cost
Disease control CompletedThis completed Phase 3 trial tested whether TEV-45779, a biosimilar of the drug omalizumab (XOLAIR), works as well as the original for people with chronic hives that don't improve with antihistamines. 608 participants received either the biosimilar or XOLAIR. The main goal was to…
Matched conditions: CHRONIC URTICARIA
Phase: PHASE3 • Sponsor: Teva Pharmaceuticals USA • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New tablet shows promise for chronic hives in small study
Symptom relief CompletedThis study tested a daily tablet called NatureU Histra Disslove in 19 adults with chronic hives. Participants took one tablet before a main meal for 28 days. The study measured how well the tablet controlled hives, reduced symptoms, and improved quality of life. Results showed ch…
Matched conditions: CHRONIC URTICARIA
Phase: NA • Sponsor: OmniSolutions Laboratory Holdings Limited • Aim: Symptom relief
Last updated Jun 27, 2026 12:39 UTC
-
Real-World data reveals omalizumab prescribing patterns for chronic hives in china
Knowledge-focused CompletedThis study examined how the drug omalizumab is prescribed in real-world practice for adults with chronic urticaria (long-term hives) in China. Researchers analyzed electronic health records from over 3,400 patients to see what doses were commonly used. The goal was to understand …
Matched conditions: CHRONIC URTICARIA
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC